Aileron Therapeutics, Inc. is a clinical-stage chemoprotection oncology company. It is focused on developing medicines to make chemotherapy safer. Its ALRN-6924 product is a MDM2/MDMX dual inhibitor that leverages its peptide drug technology, which i... Read more
MarketWatch
Yahoo
CNBC
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.